Don’t miss Berry Consultants presenting at the upcoming International Society for Biopharmaceutical Statistics (ISBS) Symposium this week.
On March 8th, Christina Saunders, Ph.D., will be presenting “Successful Implementation of Adaptive Analyses for Platform Trials: A Perspective from the Unblinded Statistical Analysis Committee (SAC)” during the 2pm EST session. Then on March 9th, Kert Viele, Ph.D., will present during the 1:30pm EST session “Controls in Platform Trials: Should a statistician ever say no to data?” See the entire ISBS program at: https://www.isbiostat.org/complete-program/